换一批
换一批Tolerance and Pharmacokinetics of Recombinant Human Endostatin Administered as Single-Dose or Multiple-Dose Infusions in Patients With Advanced Solid Tumors: A Phase I Clinical Trial.
第一作者：
Xu,Wang
第一单位：
Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China.
作者：
主题词
成年人(Adult);老年人(Aged);血管生成抑制剂(Angiogenesis Inhibitors);抗肿瘤药(Antineoplastic Agents);疾病管理(Disease Management);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物监测(Drug Monitoring);内皮抑素类(Endostatins);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤(Neoplasms);预后(Prognosis);重组蛋白质类(Recombinant Proteins);治疗结果(Treatment Outcome)
DOI
10.1177/15330338211064434
PMID
34931914
发布时间
2022-03-08
- 浏览0
Technology in cancer research & treatment
15330338211064434页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
